Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.

作者: Sabine Sembries , Heike Pahl , Stephan Stilgenbauer , Hartmut Döhner , Folke Schriever

DOI: 10.1182/BLOOD.V93.2.624

关键词: Cancer researchIntegrinCell signalingReceptorBiologySignal transductionCD58Complement receptor 1CD48Cell adhesion molecule

摘要: Deletions in chromosome bands 11q22-q23 were recently shown to be one of the most frequent aberrations B-cell chronic lymphocytic leukemia (B-CLL). Patients suffering from B-CLL with 11q deletion are characterized by extensive lymphadenopathy, rapid disease progression, and short survival times. Phenotypic functional characteristics cells that may help explain pathophysiology this entity yet unknown. In present study, (n = 19) without analyzed for their expression functionally relevant cell surface molecules 57). carried significantly lower levels adhesion CD11a/CD18 (integrin L/β2), CD11c/CD18 X/β2), CD31 (PECAM-1), CD48, CD58 (LFA-3). Furthermore, expressed less signaling receptors CD45 (leukocyte common antigen [LCA]), CD6, CD35 (complement receptor 1), CD39. Reduced low-level CD49d correlated decreased overall survival. or did not differ growth fractions, transcription factor NF-κB, response mitogenic stimuli. Decreased contribute pathogenesis subgroup deletion.

参考文章(44)
W Kasinrerk, O Majdic, S J Gadd, W Knapp, H Stockinger, B Strass, W Schreiber, E Schnabl, R Eher, Molecular characterization and functional analysis of the leukocyte surface protein CD31. Journal of Immunology. ,vol. 145, pp. 3889- 3897 ,(1990)
Timothy A. Springer, Michael L. Dustin, Takashi K. Kishimoto, Steven D. Marlin, The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune System Annual Review of Immunology. ,vol. 5, pp. 223- 252 ,(1987) , 10.1146/ANNUREV.IY.05.040187.001255
Timothy A. Springer, Adhesion receptors of the immune system. Nature. ,vol. 346, pp. 425- 434 ,(1990) , 10.1038/346425A0
B. Trauth, C Klas, A. Peters, S Matzku, P Moller, W Falk, K. Debatin, P. Krammer, Monoclonal antibody-mediated tumor regression by induction of apoptosis Science. ,vol. 245, pp. 301- 305 ,(1989) , 10.1126/SCIENCE.2787530
Stephan Stilgenbauer, Claudia Schaffner, Annette Litterst, Peter Piebisch, Shlomit Gilad, Anat Bar-Shira, Michael R. James, Peter Lichter, Hartmut Döhner, Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Medicine. ,vol. 3, pp. 1155- 1159 ,(1997) , 10.1038/NM1097-1155
S Yonehara, A Ishii, M Yonehara, A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor Journal of Experimental Medicine. ,vol. 169, pp. 1747- 1756 ,(1989) , 10.1084/JEM.169.5.1747